FDA Restricts Copycat Weight-Loss Drugs Amid Supply Shortages
The US Food and Drug Administration (FDA) will restrict the creation of copycat weight-loss drugs due to supply shortages. A federal judge declined an injunction that would have allowed compounding pharmacies to continue making more affordable versions. When demand for popular weight-loss drugs was high, the FDA allowed compounding pharmacies to create copycat drugs. However, … Read more